Article
Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response.
Pharmacogenomics - 1 Apr 2010
Tsai Ming-Hsien, Lin Keh-Ming, Hsiao Mei-Chun, Shen Winston W, Lu Mong-Liang, Tang Hwa-Sheng, Fang Chun-Kai, Wu Chi-Shin, Lu Shao-Chun, Liu Shu Chih, Chen Chun-Yu, Liu Yu-Li
Abstract excerpt
AIMS: The antidepressant escitalopram (S-CIT) is metabolized by the cytochrome-P450 (CYP) enzymes CYP 2D6, 2C19 and 3A4. This study evaluated the impact of CYP2D6, 2C19 and 3A4 genetic polymorphisms on plasma concentrations of S-CIT and patient treatment response. MATERIALS & METHODS: A total of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
